Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia

Psychiatry Res. 2014 Dec 15;220(1-2):193-6. doi: 10.1016/j.psychres.2014.07.079. Epub 2014 Aug 12.

Abstract

The neurotrophin, brain-derived neurotrophic factor (BDNF), characterises a probable neurobiochemical explanation of maldevelopments in schizophrenia and is a candidate biomarker of the illness. A paucity of studies examining neurobiochemical predictors of remission in schizophrenia exists. In this study, we seek to examine if serum BDNF level is associated with remission status in a sample of Chinese patients with schizophrenia. This study did not find a significant relationship between serum BDNF and remission in patients with schizophrenia. Identification of a suitable biomarker for diagnosis, management, and prognostic outcome is crucial and warrants further study.

Keywords: Biomarker; Neurotrophins; Psychosis; Response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People
  • Biomarkers / blood
  • Brain-Derived Neurotrophic Factor / blood*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Schizophrenia / blood*
  • Schizophrenia / diagnosis
  • Severity of Illness Index

Substances

  • Biomarkers
  • Brain-Derived Neurotrophic Factor